Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTX and Radiation in Inoperable Pancreatic Cancer
NCT00869258Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jun 2005
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel, capecitabine in pancreatic adenocarcinoma (PDAC), sponsored by Columbia University. Started Jun 2005; status: completed.
02
Drugs
gemcitabinedocetaxelcapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00869258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869258.